| Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses G Fotaki, C Jin, M Ramachandran, IK Kerzeli, A Karlsson-Parra, D Yu, ... Oncoimmunology 7 (3), e1395126, 2018 | 26 | 2018 |
| Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in … G Fotaki, C Jin, IK Kerzeli, M Ramachandran, MM Martikainen, ... Oncoimmunology 7 (3), e1397250, 2018 | 22 | 2018 |
| Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination EB Ellingsen, G Bounova, I Kerzeli, I Anzar, D Simnica, E Aamdal, ... Journal of translational medicine 20 (1), 419, 2022 | 13 | 2022 |
| Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology I Laurén, S Havervall, H Ng, M Lord, A Pettke, N Greilert‐Norin, ... Immunity, Inflammation and Disease 10 (4), e595, 2022 | 9 | 2022 |
| Three-fold higher frequency of circulating chronic lymphocytic leukemia-like B-cell clones in patients with Ph-Myeloproliferative neoplasms P Miltiades, E Lamprianidou, IK Kerzeli, E Nakou, SI Papamichos, ... Leukemia research 39 (11), 1159-1165, 2015 | 7 | 2015 |
| Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations IK Kerzeli, M Lord, M Doroszko, R Elgendy, A Chourlia, I Stepanek, ... Plos one 16 (7), e0253178, 2021 | 6 | 2021 |
| Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer IK Kerzeli, A Kostakis, P Türker, PU Malmström, T Hemdan, ... BMC cancer 23 (1), 605, 2023 | 4 | 2023 |
| Correction: Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine … IK Kerzeli, M Lord, M Doroszko, R Elgendy, A Chourlia, I Stepanek, ... Plos one 19 (5), e0304890, 2024 | | 2024 |
| MALT1 inhibition suppresses antigen-specific T cell responses IK Kerzeli, A Nasi, E Fletcher, A Chourlia, A Kallin, N Finnberg, K Ersmark, ... Cellular Immunology 397, 104814, 2024 | | 2024 |
| Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer M Lord, IK Kerzeli, P Türker, A Kostakis, PU Malmström, T Hemdan, ... | | 2022 |
| Promoting immunogenicity of synthetic long peptide vaccines based on in vivo IgG complex formation: Preclinical evaluation and clinical entry of the TET platform E Fletcher, I Kerzeli, R Cordfunke, A Nasi, G Törnqvist, R Valentijn, ... Cancer Research 82 (12), 2022 | | 2022 |
| Dissecting the Microenvironment of Urothelial Bladder Cancer: Therapy, Modelling and Biomarkers IK Kerzeli Acta Universitatis Upsaliensis, 2022 | | 2022 |
| Proximity Extension Assay reveals MMP12 in plasma as a predictor of outcome in urothelial bladder cancer IK Kerzeli, P Türker, A Kostakis, PU Malmström, T Hemdan, D Ward, ... | | 2022 |
| MALT1 inhibition suppresses T-cell dependent immune surveillance IK Kerzeli, A Nasi, E Fletcher, A Chourlia, A Kallin, N Finnberg, K Ersmark, ... | | 2022 |
| The immunological landscape in bladder cancer: a single cell RNA seq analysis of tumor bearing mouse bladders with a focus on sex differences IK Kerzeli, A Kostakis, R Elgendy, A Chourlia, S Nelander, PU Malmstrom, ... | | 2022 |
| 382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in … E Ellingsen, I Kerzeli, I Anzar, N Mensali, T Clancy, S Mangsbo, S Aamdal, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A416-A416, 2021 | | 2021 |
| Development and characterization of a novel autochthonous semi-spontaneous bladder cancer model by pathological evaluation, single cell sequencing and proteomic profiling IK Kerzeli, M Lord, I Stepanek, A Chourlia, E Larsson, R Elgendy, ... Urologic Oncology: Seminars and Original Investigations 38 (12), 896, 2020 | | 2020 |
| An exploratory proteomic study delineating the local and systemic immune-oncologic profile of urinary bladder cancer patients M Lord, I Kerzeli, P Turker, PU Malmström, T Hemdan, U Segersten, ... Urologic Oncology: Seminars and Original Investigations 38 (12), 905-906, 2020 | | 2020 |
| Development and characterization of a novel semi-spontaneous bladder cancer model by pathological evaluation, single cell sequencing and proteomic profiling of urine and serum I Kerzeli, R Elgendy, I Stepanek, M Doroszko, A Chourlia, S Nelander, ... Cancer Research 80 (16_Supplement), 1610-1610, 2020 | | 2020 |
| Early immunological events in the periphery and the TME following a local immunostimulating instillation into the bladder in the MB49 orthotopic model I Kerzeli, A Kurtinovic, A Nasi, I Stepanek, M Lord, SM Mangsbo Cancer Research 79 (13_Supplement), 501-501, 2019 | | 2019 |
